Why the study?
Biochemical identification of carotid artery stenosis remains a clinical challenge.
Can serum metabolomics profiles identify and predict the severity of extracranial carotid artery stenosis in male stroke patients compared to normal controls?
Can serum metabolomics profiles identify and predict the severity of extracranial carotid artery stenosis in male stroke patients compared to normal controls?
Answers are grounded in this paper and cite their sources.
Specific serum metabolites, including acylcarnitines, amino acids, and glycerophospholipids, show high specificity but low sensitivity for detecting carotid artery stenosis severity in male stroke patients.
The biochemical identification of carotid artery stenosis (CAS) is still a challenge. Hence, 349 male subjects (176 normal controls and 173 stroke patients with extracranial CAS ≥ 50% diameter stenosis) were recruited. Blood samples were collected 14 days after stroke onset with no acute illness. Carotid plaque score (≥2, ≥5 and ≥8) was used to define CAS severity. Serum metabolites were analyzed using a targeted Absolute IDQ®p180 kit. Results showed hypertension, diabetes, smoking, and alcohol consumption were more common, but levels of diastolic blood pressure, HDL-C, LDL-C, and cholesterol were lower in CAS patients than controls (p < 0.05), suggesting intensive medical treatment for CAS. PCA and PLS-DA did not demonstrate clear separation between controls and CAS patients. Decision tree and random forest showed that acylcarnitine species (C4, C14:1, C18), amino acids and biogenic amines (SDMA), and glycerophospholipids (PC aa C36:6, PC ae C34:3) contributed to the prediction of CAS. Metabolite panel analysis showed high specificity (0.923 ± 0.081, 0.906 ± 0.086 and 0.881 ± 0.109) but low sensitivity (0.230 ± 0.166, 0.240 ± 0.176 and 0.271 ± 0.169) in the detection of CAS (≥2, ≥5 and ≥8, respectively). The present study suggests that metabolomics profiles could help in differentiating between controls and CAS patients and in monitoring the progression of CAS.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: